Quen Joshua Cheng

Quen Cheng practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Quen Cheng's NPI, 1194091298, was assigned on March 23, 2012. Quen Cheng graduated from UC San Diego School of Medicine in 2012. Quen Cheng holds California license A126738.

Quen Cheng's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Quen Cheng's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Quen Cheng is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Quen Cheng to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Quen Cheng practices, 3 sites in all. Vendor and product names are available with a free account.

Infectious disease is Quen Cheng's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Quen Cheng is board certified in infectious disease by the American Board of Internal Medicine. Quen Cheng is licensed in California.

Dmand AI lists pneumonia among the conditions Quen Cheng treats.

CMS data shows 145 Medicare services from Quen Cheng across 3 procedure codes in 2024, for 104 Medicare patients. Medicare paid $14,922 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 104 Medicare patients who saw Quen Cheng in 2024. The largest group is 65 to 74, with 36 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 53% are also on Medicaid. Their average risk score is 4.09, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Quen Cheng's median patient age at 53, with 38% women.

In 2024, Quen Cheng wrote 52 Medicare Part D claims for 21 patients. 94% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $556 in total drug cost. In 2017, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Quen Cheng for performance year 2024, reported as part of a group. Quen Cheng accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Quen Cheng as offering telehealth.

Dmand AI links 11 papers to Quen Cheng, published from 2016 to 2024. 2018 was the busiest year, with 2. The most frequent topics are Neurons, Brain and Calcium. Quen Cheng has published most often in J Neurosci. Quen Cheng's most frequent co-authors are Tyler Christian Steed, MD, PhD, Eric Y. Chang, MD and Robert Lazarus Modlin, MD.

Quen Cheng graduated from UC San Diego School of Medicine in 2012.

Quen Cheng is in network with 12 carriers, including Aetna, Elevance and United Healthcare. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.